Variant report
Variant | nsv933790 |
---|---|
Chromosome Location | chr2:20192727-20194334 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:61)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:20194085-20194135 | AG04449 | skin: | fetal |
2 | chr2:20194085-20194135 | HCT-116 | colon: | n/a |
3 | chr2:20194085-20194135 | K562 | blood: | n/a |
4 | chr2:20194085-20194135 | MCF-7 | breast: | n/a |
5 | chr2:20194085-20194135 | PrEC | prostate: | n/a |
6 | chr2:20194085-20194135 | LNCaP | prostate: | n/a |
7 | chr2:20194085-20194135 | SK-N-SH | brain: | n/a |
8 | chr2:20194085-20194135 | AoSMC | blood vessel: | n/a |
9 | chr2:20194085-20194135 | GM12891 | blood: | n/a |
10 | chr2:20194085-20194135 | MCF10A-Er-Src | breast: | n/a |
11 | chr2:20194085-20194135 | HNPCEpiC | eye: | n/a |
12 | chr2:20194085-20194135 | RPTEC | kidney: | n/a |
13 | chr2:20194085-20194135 | ProgFib | skin: | n/a |
14 | chr2:20194085-20194135 | SKMC | muscle: | n/a |
15 | chr2:20194085-20194135 | Jurkat | blood: | n/a |
16 | chr2:20194085-20194135 | PFSK-1 | brain: | n/a |
17 | chr2:20194085-20194135 | HUVEC | blood vessel: | n/a |
18 | chr2:20194085-20194135 | CMK | blood: | n/a |
19 | chr2:20194085-20194135 | AG04450 | lung: | fetal |
20 | chr2:20194085-20194135 | HRPEpiC | eye: | n/a |
21 | chr2:20194085-20194135 | GM06990 | blood: | n/a |
22 | chr2:20194085-20194135 | T-47D | breast: | n/a |
23 | chr2:20194085-20194135 | AG10803 | skin: | n/a |
24 | chr2:20194085-20194135 | NHDF-neo | bronchial: | n/a |
25 | chr2:20194085-20194135 | ovcar-3 | ovarian: | n/a |
26 | chr2:20194085-20194135 | HIPEpiC | eye: | n/a |
27 | chr2:20194085-20194135 | Hepatocyte | liver: | n/a |
28 | chr2:20194085-20194135 | ECC-1 | luminal epithelium: | n/a |
29 | chr2:20194085-20194135 | GM12892 | blood: | n/a |
30 | chr2:20194085-20194135 | AG09309 | skin: | n/a |
31 | chr2:20194085-20194135 | HRCEpiC | kidney: | n/a |
32 | chr2:20194085-20194135 | HCF | heart: | n/a |
33 | chr2:20194085-20194135 | A549 | lung: | n/a |
34 | chr2:20194085-20194135 | NB4 | blood: | n/a |
35 | chr2:20194085-20194135 | NHBE | bronchial: | n/a |
36 | chr2:20194085-20194135 | HAEpiC | amniotic membrane: | n/a |
37 | chr2:20194085-20194135 | SK-N-SH_RA | brain: | n/a |
38 | chr2:20194085-20194135 | HepG2 | liver: | n/a |
39 | chr2:20194085-20194135 | BE2_C | brain: | n/a |
40 | chr2:20194085-20194135 | NH-A | brain: | n/a |
41 | chr2:20194085-20194135 | HMEC | breast: | n/a |
42 | chr2:20194085-20194135 | BJ | skin: | n/a |
43 | chr2:20194085-20194135 | HL-60 | blood: | n/a |
44 | chr2:20194085-20194135 | HEEpiC | esophagus: | n/a |
45 | chr2:20194085-20194135 | SAEC | small airway: | n/a |
46 | chr2:20194085-20194135 | Caco-2 | colon: | n/a |
47 | chr2:20194085-20194135 | GM12878 | blood: | n/a |
48 | chr2:20194085-20194135 | U87 | brain: | n/a |
49 | chr2:20194085-20194135 | HCM | heart: | n/a |
50 | chr2:20194085-20194135 | HRE | kidney: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:20188953..20191460-chr2:20192012..20197469,5 | MCF-7 | breast: | |
2 | chr2:20192789..20194315-chr2:20202066..20203747,2 | MCF-7 | breast: | |
3 | chr2:20172794..20174644-chr2:20194246..20195858,2 | MCF-7 | breast: | |
4 | chr2:20192256..20194117-chr2:20249842..20252483,2 | K562 | blood: | |
5 | chr2:20189892..20191955-chr2:20192120..20195267,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
WDR35 | TF binding region |
WDR35 | CpG island |
ENSG00000068697 | chromatin interactions |
ENSG00000227210 | chromatin interactions |
ENSG00000223734 | chromatin interactions |
ENSG00000118965 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374164108 | chr2:20192813-20192814 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs186870177 | chr2:20192832-20192833 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
3 | rs377607594 | chr2:20192853-20192854 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs370798785 | chr2:20192877-20192878 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs375672946 | chr2:20192880-20192881 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs201304564 | chr2:20192920-20192921 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs138400723 | chr2:20192921-20192922 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs373656041 | chr2:20192925-20192926 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs35973216 | chr2:20192931-20192932 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs566845987 | chr2:20192934-20192935 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs531961925 | chr2:20192987-20192988 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs552157884 | chr2:20192992-20192993 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs142784514 | chr2:20193017-20193018 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs201840297 | chr2:20193086-20193087 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs543546841 | chr2:20193156-20193157 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs117754097 | chr2:20193203-20193204 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs554784490 | chr2:20193278-20193279 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs191294078 | chr2:20193367-20193368 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs372862017 | chr2:20193393-20193394 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs76406844 | chr2:20193434-20193435 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs557946709 | chr2:20193521-20193522 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs147409847 | chr2:20193552-20193553 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs577071558 | chr2:20193554-20193555 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs34742301 | chr2:20193645-20193646 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs75669705 | chr2:20193649-20193650 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs540049890 | chr2:20193653-20193654 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs13389848 | chr2:20193685-20193686 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs558951627 | chr2:20193785-20193786 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs138180842 | chr2:20193793-20193794 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs55919320 | chr2:20193826-20193827 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs561061901 | chr2:20193856-20193857 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs184346062 | chr2:20193922-20193923 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs115095286 | chr2:20193947-20193948 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs371255343 | chr2:20194006-20194007 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs371504208 | chr2:20194018-20194019 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs532878508 | chr2:20194019-20194020 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs3820949 | chr2:20194036-20194037 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs370974076 | chr2:20194050-20194051 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs568861104 | chr2:20194060-20194061 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs368657984 | chr2:20194085-20194086 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
41 | rs531293171 | chr2:20194117-20194118 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
42 | rs548276148 | chr2:20194137-20194138 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs371946052 | chr2:20194141-20194142 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs542215191 | chr2:20194151-20194152 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs376797243 | chr2:20194181-20194182 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs143711983 | chr2:20194186-20194187 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs376389357 | chr2:20194197-20194198 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs369200555 | chr2:20194198-20194199 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs547622818 | chr2:20194249-20194250 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs570646592 | chr2:20194264-20194265 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ependymoma | 16718352 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Neuroblastoma | 19638189 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Medulloblastoma | 22160402 | CNVD |
Schizophrenia | 22118685 | CNVD |
Epilepsy | 22118685 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 18765546 | CNVD |
Neuroblastoma | 18281664 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Neuroblastoma | 19738985 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:20190400-20194600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:20190400-20207400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr2:20190600-20192800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:20190600-20193200 | Weak transcription | Fetal Lung | lung |
5 | chr2:20190600-20201000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr2:20190600-20211400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr2:20190800-20195800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:20190800-20205000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr2:20190800-20208400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr2:20191000-20211200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr2:20191400-20192800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr2:20191400-20194800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr2:20191400-20208000 | Weak transcription | A549 | lung |
14 | chr2:20191600-20196200 | Weak transcription | HepG2 | liver |
15 | chr2:20192800-20194200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr2:20192800-20195400 | Strong transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr2:20193200-20194400 | Enhancers | Fetal Lung | lung |